CD8A and neoplasm: Treatment with an anti-CD25 neutralizing antibody reduced their suppressive capacity, thereby increasing CD8+ T cell cytotoxic functions; interestingly, a combination of anti-CD25 treatment and DC vaccination resulted in tumor rejection in 100% of challenged mice [52].